For Providers

You can give your patients access to life-saving prostate cancer early detection technology.

As a physician, there’s a good chance you’ve seen this scenario unfold time and time again. Your patient has a PSA of 4 ng/ml or above, so you refer him to a urologist for further testing. The urologist, following today’s accepted standard of care, may subject your patient to a highly ineffective digital rectal exam, and then possibly a biopsy – a procedure that’s painful and not very accurate. Neither avenue is totally reliable when it comes to detecting prostate legions, with success rates of less than 50%. This low success rate could mean that a lesion is missed in its early stages, with damaging or fatal results later on.

The growing popularity of MRI screening

MRI scans are now being utilized by the top 25 research hospitals in the U.S. as an alternative to digital rectal exams and as a means of avoiding unnecessary biopsies. An MRI can reliably detect whether or not a tumor is present. If no tumor is suspected, the patient will not need a biopsy. However, most MRI systems use an endo-rectal probe when screening for prostate cancer. Not only is it invasive (an antenna is inserted into the rectum); it’s also expensive.

FirstScan™ offers a better MRI for early prostate cancer detection

FirstScan utilizes the latest biparametric MRI technology (bpMRI), combined with top-tier MRI systems, to offer a new form of early prostate cancer detection through the use of advanced MRI technology.  As opposed to the commonly used endo-rectal probe, FirstScan features ScanMed®’s novel, wearable, non-invasive MRI coil for scanning. The coil, made up of multiple antenna resonators, allows for better reception and improved image quality. Throughout the quick scan, the patient lies comfortably in the MRI system. No needles. No probes.

In addition to being comfortable and non-invasive, FirstScan stands out from other screening methods because it is:

Compared to the less-than-50% success rates of digital rectal exams and non-image-guided biopsies, the high-quality imaging available through bpMRI technology brings the predictive value of detecting cancer to 80-90%. This huge improvement in accuracy can lead to early detection and lives saved.

The entire procedure lasts about 30 minutes, and you will receive your patient’s radiologist report within 1-3 business days.

The cost of a FirstScan MRI is $595 to your patient, including the radiologist report. This affordable price is less than the typical out-of-pocket co-pay for an insurance-paid MRI.

Several of the top 25 research hospitals and providers that utilize MRI technology, including The Mayo Clinic and UTMB Health, have purchased ScanMed’s patented antenna in order to significantly enhance image quality and improve their diagnostic efficacy.

Our clinic is located just off of I-80, for convenient access from virtually anywhere in the region. We’re focused on patient satisfaction, and we will ensure that your patient is able to get in for his screening as soon as possible.

We realize that the Standard of Care today doesn’t specify PCa screening. Because of this, FirstScan will be collecting data under a research study (IRB) with the intention of publishing results to prove the clinical merit of MRI Prostate Cancer Screening. 

Learn more about the top urologists, board certified radiologists, scientists and innovators behind FirstScan.
Meet the executive team

Have a patient with an elevated PSA?
Encourage him to make an appointment today.

The sooner we see a patient, the sooner we can deliver peace of mind and lifesaving early detection. Have your patient schedule via phone by calling (402) 934-1999.

You can also learn more about FirstScan by visiting our News & Resources page.